Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups.

scientific article published on January 2015

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4161/15384047.2014.986997
P932PMC publication ID4622499
P698PubMed publication ID25517601
P5875ResearchGate publication ID269772184

P50authorMartine AmiotQ39395922
Philippe MoreauQ87734443
P2093author name stringCatherine Pellat-Deceunynck
Sophie Maïga
Patricia Gomez-Bougie
Catherine Godon
Charlotte Kervoëlen
Maxime Halliez
P2860cites workMolecular pathogenesis of multiple myeloma: basic and clinical updatesQ27026205
Emerging Bcl-2 inhibitors for the treatment of cancerQ33682689
Mutations in TP53 are exclusively associated with del(17p) in multiple myelomaQ34255215
The molecular classification of multiple myelomaQ34530992
Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension studyQ34637209
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell linesQ34750568
Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivoQ36916903
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice modelQ37223850
Current trends in autologous stem-cell transplantation for myeloma in the era of novel therapiesQ37863988
The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myelomaQ37946246
Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other.Q39048347
Cell death via DR5, but not DR4, is regulated by p53 in myeloma cells.Q39324268
ABT-737 is highly effective against molecular subgroups of multiple myelomaQ39491434
Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myelomaQ40124624
Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphomaQ40397270
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.Q40420617
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma CellsQ40633129
Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cellsQ41129636
Apoptotic machinery diversity in multiple myeloma molecular subtypesQ41807395
The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cellsQ42543880
Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53.Q43804591
Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosisQ44834826
Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.Q52546411
P4510describes a project that usesImageJQ1659584
P433issue1
P921main subjectcurcuminQ312266
cell deathQ2383867
P304page(s)60-65
P577publication date2015-01-01
P1433published inCancer Biology and TherapyQ2544651
P1476titleCurcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
P478volume16

Reverse relations

cites work (P2860)
Q37671719Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma
Q39016579Cucurmin, anticancer, & antitumor perspectives: A comprehensive review.
Q89388701Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer
Q49736620Long-term stabilisation of myeloma with curcumin

Search more.